PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical OncologyFederica Miglietta, Stefania Gori, Michela Cinquini et al.|The Breast|2022Cited by 16
Analysis of patients with locally advanced rectal cancer given neoadjuvant radiochemotherapy with or without RT dose intensification: A multicenter retrospective study – ATLANTIS part ILuca Nicosia, Mattia Falchetto Osti, Fatemeh Jafari et al.|Radiotherapy and Oncology|2024Cited by 12
Anaemia in cancer patients: Advances and challenges in the era of precision oncologyFederica Miglietta, Alessandra Gennari, Mario Pirozzi et al.|Critical Reviews in Oncology/Hematology|2025Cited by 11
Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus projectStefania Gori, Paolo Tralongo, Fiorenza De Rose et al.|Cancer Treatment Reviews|2024Cited by 2
The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectivesStefania Gori, Riccardo Gerosa, Michela Cinquini et al.|Tumori Journal|2025Cited by 1